Fujifilm Diosynth Biotechnologies Unveils Strategic Customer-Focused Business Structure

[ad_1] FUJIFILM Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, disclosed a new strategic business unit (SBU) structure to provide tailored…

Gene Editing Will Change Medicine—and Maybe Health Investing Too

[ad_1] It usually takes time for scientific discoveries in the lab to make their way to the market. The groundbreaking gene-editing technology known as Crispr, which acts like a molecular…

New Treatment for Bladder Cancer Offers This Biotech a Second Chance

[ad_1] UroGen hopes to have success with a new treatment after its first drug was a commercial flop. [ad_2] Source link

Ozempic Settles the Obesity Debate: It’s Biology Over Willpower

[ad_1] Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. [ad_2] Source link

Pfizer’s Covid Boost Crashes to Earth

[ad_1] This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or…

Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall

[ad_1] The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. [ad_2] Source link

Deadly Fungi Are Becoming More Common And We’re Running Out of Ways to Treat Them

[ad_1] Research suggests fungicides are weakening antifungals before they are up for approval. [ad_2] Source link

The $76 Billion Diet Industry Asks: What to Do About Ozempic?

[ad_1] Weight-loss businesses, which long pushed calorie-counting and willpower, are grappling with the surging popularity of new drugs. [ad_2] Source link

Drug manufacturing facility gets green light thanks to federal dollars

[ad_1] Alberta’s burgeoning biomanufacturing and life sciences industry got an $80.5-million boost in federal funding today, putting it at the centre of efforts to commercialize new discoveries and give Canadians…

WSJ News Exclusive | New Drugs for Cancer, Rare Disease Can Now Cost More Than $20,000 a Month

[ad_1] WSJ News Exclusive Health Trend follows rising pressure on companies to rein in repeat or annual price hikes for older drugs [ad_2] Source link